Key Takeaways
- • A California appellate court is reviewing a case in which a private equity firm fired a physician owner after the sale of a medical practice's tangible assets, raising questions about whether nonphysician entities can control clinical decisions in physician-owned practices.
- • The case, *Art Center Holdings Inc. et al v. WCE CA Art LLC et al.* (California Court of Appeal, Second District), centers on whether a "lay manager" corporate structure violated California's century-old corporate practice of medicine law, with the lower court finding that the PE firm improperly controlled clinical operations.
- • Private equity investment in physician practices has accelerated dramatically: PE-backed practices increased sixfold from 75 in 2012 to 484 in 2021, making the legal and regulatory interpretation of physician independence increasingly material to the investment landscape.
- • The California Medical Association filed an amicus brief supporting the lower court's receivership order, arguing that corporate practice of medicine law "must be applied with precision to avoid unintended consequences in the industry" as PE presence in healthcare expands.
- • Multiple states (Washington, New Mexico, Vermont, and Maine) have introduced bills banning or restricting private equity interference in medical practice, signaling potential regulatory headwinds for PE healthcare acquisitions.
Summary
A significant legal dispute in California is poised to reshape private equity's ability to control physician practices through corporate structures. The California Court of Appeal, Second District, is reviewing *Art Center Holdings Inc. et al v. WCE CA Art LLC et al.*, a case originating from a PE firm's acquisition of a fertility practice's tangible assets. The core issue: whether nonphysician entities can terminate a physician owner who exercises independent clinical judgment, and whether such actions constitute unlawful corporate practice of medicine.
The original dispute began when the private equity firm demanded that the physician-owner fire two employee physicians. When the physician-owner refused, the PE firm terminated the physician owner instead—a move that triggered legal action and a lower court receivership order. The Los Angeles Superior Court found that the professional corporation structure "resulted in lay managers improperly controlling a clinical aspect of a medical practice," determining that this arrangement violated California's corporate practice of medicine statute, a law dating back over a century.
The California Medical Association has intervened in the appeal through an amicus brief, explicitly supporting the lower court's receivership determination. Rather than argue the case's direct merits, the CMA emphasized that California's corporate practice of medicine law "must be applied with precision to avoid unintended consequences in the industry." This reflects broader institutional concern about PE's expanding footprint in healthcare. Private equity investment in physician practices has accelerated substantially: deal volume increased sixfold from 75 practices in 2012 to 484 in 2021, according to analysis cited in the primary source.
The timing of this appellate review carries strategic importance for PE investors. Concurrently, legislative momentum is building against PE healthcare interference; lawmakers in Washington, New Mexico, Vermont, and Maine have recently introduced bills specifically banning corporate practice of medicine arrangements that allow financial investors to control physician decision-making. The appellate court's interpretation of California's century-old statute will likely influence regulatory approaches across multiple jurisdictions and determine the operational and financial viability of PE-backed physician practice models going forward.
The original dispute began when the private equity firm demanded that the physician-owner fire two employee physicians. When the physician-owner refused, the PE firm terminated the physician owner instead—a move that triggered legal action and a lower court receivership order. The Los Angeles Superior Court found that the professional corporation structure "resulted in lay managers improperly controlling a clinical aspect of a medical practice," determining that this arrangement violated California's corporate practice of medicine statute, a law dating back over a century.
The California Medical Association has intervened in the appeal through an amicus brief, explicitly supporting the lower court's receivership determination. Rather than argue the case's direct merits, the CMA emphasized that California's corporate practice of medicine law "must be applied with precision to avoid unintended consequences in the industry." This reflects broader institutional concern about PE's expanding footprint in healthcare. Private equity investment in physician practices has accelerated substantially: deal volume increased sixfold from 75 practices in 2012 to 484 in 2021, according to analysis cited in the primary source.
The timing of this appellate review carries strategic importance for PE investors. Concurrently, legislative momentum is building against PE healthcare interference; lawmakers in Washington, New Mexico, Vermont, and Maine have recently introduced bills specifically banning corporate practice of medicine arrangements that allow financial investors to control physician decision-making. The appellate court's interpretation of California's century-old statute will likely influence regulatory approaches across multiple jurisdictions and determine the operational and financial viability of PE-backed physician practice models going forward.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.